Menu
GeneBe

1-43453697-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001190880.3(HYI):ā€‹c.97G>Cā€‹(p.Glu33Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000266 in 1,437,294 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00012 ( 0 hom., cov: 33)
Exomes š‘“: 0.00028 ( 0 hom. )

Consequence

HYI
NM_001190880.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0200
Variant links:
Genes affected
HYI (HGNC:26948): (hydroxypyruvate isomerase (putative)) This gene encodes a putative hydroxypyruvate isomerase, which likely catalyzes the conversion of hydroxypyruvate to 2-hydroxy-3-oxopropanoate, and may be involved in carbohydrate transport and metabolism. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0739792).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HYINM_001190880.3 linkuse as main transcriptc.97G>C p.Glu33Gln missense_variant 1/8 ENST00000372430.9
SZT2NM_001365999.1 linkuse as main transcriptc.*3217C>G 3_prime_UTR_variant 72/72 ENST00000634258.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HYIENST00000372430.9 linkuse as main transcriptc.97G>C p.Glu33Gln missense_variant 1/81 NM_001190880.3 P1Q5T013-1
SZT2ENST00000634258.3 linkuse as main transcriptc.*3217C>G 3_prime_UTR_variant 72/725 NM_001365999.1 P1Q5T011-1

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152064
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.0000216
AC:
1
AN:
46224
Hom.:
0
AF XY:
0.0000358
AC XY:
1
AN XY:
27922
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000979
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000282
AC:
363
AN:
1285230
Hom.:
0
Cov.:
40
AF XY:
0.000275
AC XY:
174
AN XY:
632704
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000302
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000324
Gnomad4 OTH exome
AF:
0.000132
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152064
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74284
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000250
Gnomad4 OTH
AF:
0.000479
Bravo
AF:
0.000106
ExAC
AF:
0.0000385
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2021The c.97G>C (p.E33Q) alteration is located in exon 1 (coding exon 1) of the HYI gene. This alteration results from a G to C substitution at nucleotide position 97, causing the glutamic acid (E) at amino acid position 33 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
13
DANN
Benign
0.92
DEOGEN2
Benign
0.024
T;T;T;.;T
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.75
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.77
T;T;T;T;T
M_CAP
Pathogenic
0.29
D
MetaRNN
Benign
0.074
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.080
N;.;.;N;.
MutationTaster
Benign
1.0
D;N;N;N
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
0.14
N;.;.;N;N
REVEL
Benign
0.026
Sift
Benign
0.37
T;.;.;T;T
Sift4G
Benign
0.60
T;T;T;T;T
Polyphen
0.0
B;.;.;.;.
Vest4
0.071
MutPred
0.51
Gain of MoRF binding (P = 0.0718);Gain of MoRF binding (P = 0.0718);Gain of MoRF binding (P = 0.0718);Gain of MoRF binding (P = 0.0718);Gain of MoRF binding (P = 0.0718);
MVP
0.39
MPC
0.055
ClinPred
0.054
T
GERP RS
-0.070
Varity_R
0.17
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs775021587; hg19: chr1-43919368; API